摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(4-ethyl-phenyl)-3-methyl-butan-1-one | 137128-80-4

中文名称
——
中文别名
——
英文名称
1-(4-ethyl-phenyl)-3-methyl-butan-1-one
英文别名
1-(4-Aethyl-phenyl)-3-methyl-butan-1-on;1-(4-Ethylphenyl)-3-methylbutan-1-one
1-(4-ethyl-phenyl)-3-methyl-butan-1-one化学式
CAS
137128-80-4
化学式
C13H18O
mdl
——
分子量
190.285
InChiKey
VCIGKTPSWBUYFI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    268-270 °C(Press: 722 Torr)
  • 密度:
    0.9570 g/cm3

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    14
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.46
  • 拓扑面积:
    17.1
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Propiophenone derivatives and their preparation and pharmaceutical use
    摘要:
    本发明涉及通式I表示的化合物,其中X₁,X₂代表氢,C₁₋₄-烷基苯基,卤素,C₁₋₄-烷氧基或与C₁₋₄-烷基基团的双烷基胺,或X₁和X₂一起代表苯亚甲基或茚-2,3-二基,Z₁,Z₂代表氢或羟基,或一起代表氧或-O(CH₂)₂O-,Y₁,Y₂代表氢,C₁₋₃-烷基或苯基,A代表从环胺衍生的基团,n代表0,1或2,以游离碱形式或以加成盐的形式,优选为药学上可接受的盐,用于它们的制备方法,以及作为中枢肌肉松弛剂和抗惊厥药物的药用。
    公开号:
    EP0423524A3
  • 作为产物:
    描述:
    乙基苯异戊酰氯 在 zinc(II) chloride 作用下, 生成 1-(4-ethyl-phenyl)-3-methyl-butan-1-one
    参考文献:
    名称:
    Kutschkarow; Zukerwanik, Zhurnal Obshchei Khimii, 1948, vol. 18, p. 320,322
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • 6-ARYLALKYLAMINO-2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS
    申请人:BRINER Karin
    公开号:US20110269745A1
    公开(公告)日:2011-11-03
    The present invention provides 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines of Formula (I) as selective 5-HT2c receptor agonists for the treatment of 5-HT2c associated disorders including obesity, obsessive/compulsive disorder, depression, and anxiety, where, R6 is —NR10R11, where R10 is substituted phenylalkyl or substituted pyridylalkyl and other substituents are as defined in the specification.
    本发明提供了6-取代的2,3,4,5-四氢-1H-苯并[d]氮杂环化合物,其化学式为(I),作为选择性5-HT2c受体激动剂,用于治疗5-HT2c相关疾病,包括肥胖症、强迫症、抑郁症和焦虑症,其中,R6是—NR10R11,其中R10是取代的苯基烷基或取代的吡啶基烷基,其他取代基如规范中所定义。
  • Substituted pyrazoles as P38 kinase inhibitors
    申请人:G.D. Searle LLC
    公开号:EP1500657B1
    公开(公告)日:2007-09-19
  • CONJUGATES COMPRISING CELL-BINDING AGENTS AND CYTOTOXIC AGENTS
    申请人:ImmunoGen, Inc.
    公开号:US20160095938A1
    公开(公告)日:2016-04-07
    The invention relates to novel cell-binding agent-cytotoxic agent conjugates, wherein the cell-binding agent (CBA) is covalently linked to the cytotoxic agent through an aldehyde group obtained from oxidation of a 2-hydroxyethylamine moiety on the CBA. The invention also provides methods of preparing the conjugates of the present invention. The invention further provides composition and methods useful for inhibiting abnormal cell growth or treating a proliferative disorder in a mammal using the conjugates of the invention.
  • US8680091B2
    申请人:——
    公开号:US8680091B2
    公开(公告)日:2014-03-25
  • Propiophenone derivatives and their preparation and pharmaceutical use
    申请人:MARUHO Co., Ltd.
    公开号:EP0423524A3
    公开(公告)日:1992-07-08
    The present invention relates to compounds represented by the general formula I in which X₁, X₂represent hydrogen, C₁₋₄-alky phenyl, halogen, C₁₋₄-alkoxy or dialkylamino with C₁₋₄-alkyl groups, or X₁ and X₂ together represent phenylene or indane-2,3-diyl,Z₁, Z₂represent hydrogen or hydroxy, or together represent oxygen or -O(CH₂)₂O-,Y₁, Y₂represent hydrogen, C₁₋₃-alkyl or phenyl,Arepresents a group derived from a cyclic amine, andnrepresents 0, 1 or 2, in the form of the free base or in the form of addition salts, preferably pharmaceutically acceptable salts, to methods for their preparation, and to their pharmaceutical use as central muscle relaxants and anticonvulsives.
    本发明涉及通式I表示的化合物,其中X₁,X₂代表氢,C₁₋₄-烷基苯基,卤素,C₁₋₄-烷氧基或与C₁₋₄-烷基基团的双烷基胺,或X₁和X₂一起代表苯亚甲基或茚-2,3-二基,Z₁,Z₂代表氢或羟基,或一起代表氧或-O(CH₂)₂O-,Y₁,Y₂代表氢,C₁₋₃-烷基或苯基,A代表从环胺衍生的基团,n代表0,1或2,以游离碱形式或以加成盐的形式,优选为药学上可接受的盐,用于它们的制备方法,以及作为中枢肌肉松弛剂和抗惊厥药物的药用。
查看更多